ACE Report Cover
Analysis of various THA interventions for the treatment of end stage arthritis of the hip
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
ARTHROPLASTY
Analysis of various THA interventions for the treatment of end stage arthritis of the hip .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2014;2(18):14 PLoS One. 2014 Jul 8;9(7):e99804

Results from 14 RCTs and 5 systematic reviews were reviewed and pooled to determine the effect various THA interventions had on the pain, disability, and function experienced by patients with end stage arthritis of the hip. Results from the analysis indicated that patients experienced significant postoperative THA improvements in Harris Hip scores between 6 months and 10 years, but that improvements did not differ between various impact types. Additionally, a reduced risk of implant dislocation following intervention was noted for patients treated with a larger femoral head size or cemented cups (compared to smaller femoral heads and cementless cups, respectively). Those who received cross linked cup liners experienced reduced femoral head penetration and revision when compared to conventional polyethylene liners. Analysis of femoral stem fixation methods and cup shell designs indicated that neither had a significant effect on implant survival rates.


Dettagli sul finanziamento della pubblicazione +
Finanziamento:
Non-Industry funded
Sponsor:
the National Institute for Health Research, Health Technology Assessment Programm
Conflicts:
None disclosed

Rischio di pregiudizio

9,5/10

Criteri di segnalazione

19/20

Indice di fragilità

N/A

Were the search methods used to find evidence (original research) on the primary question or questions stated?

Was the search for evidence reasonably comprehensive?

Were the criteria used for deciding which studies to include in the overview reported?

Was the bias in the selection of studies avoided?

Were the criteria used for assessing the validity of the included studies reported?

Was the validity of all of the studies referred to in the text assessed with use of appropriate criteria (either in selecting the studies for inclusion or in analyzing the studies that were cited)?

Were the methods used to combine the findings of the relevant studies (to reach a conclusion) reported?

Were the findings of the relevant studies combined appropriately relative to the primary question that the overview addresses?

Were the conclusions made by the author or authors supported by the data and or analysis reported in the overview?

How would you rate the scientific quality of this evidence?

Sì = 1

Incerto = 0,5

Non rilevante = 0

No = 0

La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.

4/4

Introduction

4/4

Accessing Data

4/4

Analysing Data

4/4

Results

3/4

Discussion

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.

Perché questo studio era necessario ora?

The enhancement of designs, fixation methods, sizes, and bearing surfaces of implants for total hip arthroplasty (THA) has produced substantial procedural options for healthcare professionals and orthopaedic surgeons. This variety of potential approaches to TKA warrants an investigation to determine the most optional combinations of THR implants and techniques. The goal of this this systematic review and meta-analysis was to evaluate the clinical effectiveness of different types of THA used for the treatment of end stage arthritis, and to attempt to determine which techniques/ interventions are the most effective.

Qual era la domanda di ricerca principale?

How effective are various THA interventions at improving the pain and disability experienced by patients with end stage arthritis of the hip?

Caratteristiche dello studio +
Data Source:
An electronic search of the databases: MEDLINE, MEDLINE In-Process, Embase, Science Citation Index, Cochrane Library (Cochrane Database of Systematic Reviews and Cochrane Central Register of Controlled Trials), Current Controlled Trials, ClinicalTrials.gov, Database of Abstracts of Reviews of Effectiveness (DARE), and HTA databases was conducted from 2008 to December 2012.
Index Terms:
Index terms used were not provided within this report or its appendices.
Study Selection:
Authors of the study examined reports to ensure that all included studies were English language RCTs or systematic reviews comparing different types of primary THR. Populations within the studies had to include patients with end stage hip arthritis (who had failed non-surgical intervention). Studies had to be comparing the composition/material, design, bearing surface, fixation method, or size of components. Studies with a population size <100 were excluded to avoid evidence with inconclusive findings.
Data Extraction:
Two independent reviewers extracted all outcomes. Discrepancies were resolved by a third reviewer. Primary outcomes extracted were: measures of hip functions and symptoms (HHS, Oxford Hip, WOMAC), mortality and causes, risk of revision, and femoral head penetration rate. Secondary outcomes extracted were: Validated clinical/functional measures (McMaster-Toronto Arthritis patient Preference Disability Questionnaire (MACTAR), Merle D’Aubigne Postel, UCLA score, health related quality of life, and peri/post procedural complications. Study characteristics, demographic information, and intervention/comparator types were also extracted.
Data Synthesis:
Pooling of studies was based on the degree of similarity in the methodological and clinical characteristics. Post-treatment mean difference (MD) for continuous outcomes and risk ratios (RR) for binary outcomes were pooled using a random-effects-model. Dichotomous outcomes with low event rates were pooled as RR using Matel-Haenszel (MH) fixed effect models. Dichotomous outcomes for studies with very low event rates (<5.0%) or zero events in one of the treatment arms were pooled as odds ratios (OR) using the Peto fixed effect model. Heterogeneity was assessed using the I-squared statistic.
Quali erano i risultati importanti?
  • Searches by the authors identified 1,523 unique records, of which, 14 RCTs and 5 systematic reviews were included.
  • 7 studies reported mean postoperative Harris Hip score between 6 months and 10 years. Results across the studies suggested that Harris Hip score improved in all interventions, but did not improve by significantly greater amounts when comparing patients treated with cemented and cementless cup fixation, between XLPE and transitional polyethylene cup liners, cemented and cementless stem fixation, metal on metal and metal on XLPE femoral head articulations, or ceramic on ceramic and metal on XLPE head articulations (p>0.05 for all).
  • No differences were apparent between patients treated with XLPE or traditional PE cup liners when comparing WOMAC or Short Form-12 scores (p>0.05).
  • A reduced risk of implant dislocation with the use of cemented cups was noticed when comparing its results against cementless cups (OR: 0.34, 95% CI: 0.13 to 0.89). A similar finding was found in favour of larger femoral head sizes (36 mm vs. 28 mm).
  • Three RCTs indicated that patients with XLPE cup liners experienced a reduction in femoral head penetration rate and risk of revision (RR: 0.18; 95% CI: 0.04 to 0.78) when compared to those who received conventional PE cup liners.
  • Analysis indicated that Femoral stem fixation and cup shell design had no significant effect on implant survival rates (p>0.05)
  • Patients who received ceramic on ceramic articulations experienced a reduced risk of osteolysis when compared to those treated with XLPE head articulations
Che cosa devo ricordare di più?

Results from the systematic review and meta-analysis indicated that patients experienced significant postoperative THA improvements in Harris Hip scores at 6 months to 10 years, but that improvements did not differ between various impact types. A reduced risk of implant dislocation following intervention was noted for patients treated with a larger femoral head size or cemented cups (compared to smaller femoral heads and cementless cups, respectively). Those who received cross linked cup liners experienced reduced femoral head penetration and revision when compared to conventional polyethylene liners. Analysis of femoral stem fixation methods and cup shell designs indicated that neither had a significant effect on implant survival rates.

Come influenzerà l'assistenza ai miei pazienti?

The majority of evidence obtained in this systematic review and meta-analysis was inconclusive due to poor reporting, missing data, or uncertain treatment estimates. The findings warrant cautious interpretation given the potential risk of bias, methodological limitations (small sample size, low event counts, short follow-up), and weak reporting of some studies included in this review. Long-term, detailed, RCTs on the topics included in this report are needed for more definitive conclusions.

DISCLAIMER

Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.

0 di 4 articoli mensili GRATUITI sbloccati
Ha raggiunto il suo limite di 4 visualizzazioni di articoli gratuiti questo mese

Accesso a OrthoEvidence a soli 1,99 dollari a settimana.

Rimanga in contatto con le ultime prove. Può disdire in qualsiasi momento.
  • Valutazioni critiche dei più recenti studi randomizzati controllati ad alto impatto e delle revisioni sistematiche in ortopedia.
  • Accesso ai contenuti del podcast OrthoEvidence, tra cui collaborazioni con il Journal of Bone and Joint Surgery, interviste con chirurghi di fama internazionale e tavole rotonde su notizie e argomenti ortopedici.
  • Abbonamento a The Pulse, una newsletter bisettimanale basata sulle evidenze scientifiche, progettata per aiutarla a prendere decisioni cliniche migliori.
Upgrade
Bentornato!
Ha dimenticato la password?
Inizi la sua prova gratuita oggi stesso!

Il suo account sarà affiliato a
e includerà l'accesso gratuito a OrthoEvidence


O
Ha dimenticato la password?

O
Controlli la sua e-mail

Se esiste un account con l'indirizzo e-mail fornito, le verrà inviata un'e-mail di reimpostazione della password. Se non vede l'e-mail, controlli la cartella spam o posta indesiderata.

Per ulteriore assistenza, contatti il nostro team di supporto.

Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Tradurre il Rapporto ACE

OrthoEvidence utilizza un servizio di traduzione di terze parti per rendere i contenuti accessibili in più lingue. Si prega di notare che, sebbene venga fatto ogni sforzo per garantire l'accuratezza, le traduzioni potrebbero non essere sempre perfette.

Come citare questo documento ACE Report

OrthoEvidence. Analysis of various THA interventions for the treatment of end stage arthritis of the hip. OE Journal. 2014;2(18):14. Available from: https://myorthoevidence.com/AceReport/Show/analysis-of-various-tha-interventions-for-the-treatment-of-end-stage-arthritis-of-the-hip

Copiare la citazione
Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Funzionalità per i membri Premium

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence Premium.

Condividi questo articolo ACE Report